About
Management
Technology
Products
Opioid Epidemic
Copay Card
Press Release/Media
Select Page
Business Development
Search
Search
Recent Posts
Protega announces FDA’s approval of their RoxyBond 10mg tablets
Protega Pharmaceuticals™ LLC Announces Commercialization of RoxyBond™ (oxycodone hydrochloride) Tablets CII in the U.S.
A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Intranasal Human Abuse Potential Study of Oxycodone ARIR, A Novel, Immediate-Release, Abuse-Deterrent Formulation
Recent Comments
No comments to show.
